Simplex Trading’s Avita Medical RCEL Stock Holding History

Simplex Trading’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,000	Closed	-$10K	–	9877
2025 Q2	$10K	Buy	2,000 +600	+43%	+$4.37K	﹤0.01%	7331
2025 Q1	$11K	Buy	+1,400	New	+$13.1K	﹤0.01%	7048
2024 Q4	–	Sell	-100	Closed	-$1K	–	9426
2024 Q3	$1K	Sell	100 -7,600	-99%	-$71.4K	﹤0.01%	8256
2024 Q2	$60K	Buy	+7,700	New	+$73.2K	﹤0.01%	5893
2024 Q1	–	Sell	-10,100	Closed	-$138K	–	9687
2023 Q4	$138K	Buy	10,100 +8,800	+677%	+$101K	﹤0.01%	5055
2023 Q3	$18K	Sell	1,300 -11,000	-89%	-$186K	﹤0.01%	6717
2023 Q2	$209K	Sell	12,300 -600	-5%	-$8.8K	﹤0.01%	4250
2023 Q1	$180K	Buy	+12,900	New	+$137K	﹤0.01%	4456
2021 Q2	–	Sell	-33	Closed	-$65K	–	10597
2021 Q1	$65K	Buy	33 +27	+450%	+$628	﹤0.01%	6300
2020 Q4	$10K	Buy	6 +1	+20%	+$22	﹤0.01%	7425
2020 Q3	$12K	Sell	5 -90	-95%	-$2.24K	﹤0.01%	6712
2020 Q2	$290K	Buy	+95	New	+$2.9K	﹤0.01%	3566

Other funds holding RCEL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplex Trading's RCEL Position: Q1 2026 in Review

Simplex Trading opened a new position in Avita Medical (RCEL) in Q1 2026: 4 shares worth $14. The stake represents ﹤0.01% of the portfolio and ranks #8922 among its holdings. This is a return to the name: Simplex Trading previously reported a position in RCEL as recently as Q1 2025.

Simplex Trading first reported a position in RCEL in Q2 2020 and has held it in 16 quarters since. The position peaked at $253K in Q2 2022. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

Simplex Trading held 4 shares of Avita Medical worth $14 as of Q1 2026.
Avita Medical was a new Simplex Trading position in Q1 2026.
Avita Medical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8922 holding.
Simplex Trading first reported a position in Avita Medical in Q2 2020 and has held it in 16 quarters since.
Simplex Trading's Avita Medical position peaked at $253K in Q2 2022.
79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.